Motif BioSciences is a biotechnology company founded in 2003 with a focus on population genetics. The company's mission is to identify the genetic causes of major diseases by harnessing a rich source of human genetic data collected from diverse populations globally. Motif BioSciences collaborates with this exceptional and robust source of human genetic data to drive its research and development efforts in the health care sector.
The company recently secured a £2.70MPost-IPO Equity investment on 26 March 2019, showcasing investor confidence in its innovative approach to population genetics. The funding indicates a potential for growth and advancement in the field of genetic research and its applications to healthcare.
